Lilly Oncology Medical
@LillyOncMed
Dedicated to communicating the latest science & disease state education from Lilly Oncology. Intended for U.S. HCPs. Community Guidelines:
๊ฐ์
March 2022
599 ํ๋ก์ ์ค 6.5K ํฌ
๐ฌ FRAmework-01 | Now Enrolling
A phase 3 trial evaluating a FRฮฑ-targeting ADC in patients with Ovarian Cancer.
Key details:
- Enrolling PSOC and PROC
- All FRฮฑ expression levels
- Allows prior mirvetuximab
Click the image for trial & enrollment info
๋ ๋ณด๊ธฐ
